Christopher Beuer, MD
Anesthesiology · Saint Louis, MONPI 1144482563
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $723,095 of the $904,610 with a category attached, or 79.9%. Medtronic accounts for 95.6% of it on its own, with 54 other manufacturers making up the rest. 2025 is the largest year on record at $200,923, 3.1 times the $65,459 reported in 2019. Among anesthesiology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 2,053 payments — averaging $440.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$865K
- Vertos Medical, Inc.$9K
- Abbott$8K
- Flowonix Medical Incorporated$7K
- Tersera Therapeutics LLC$7K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- plus $8K from 49 others
Across 58 payments — averaging $2591.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$150K
What the payments were for
- Consulting fees$57,3916%
- Speaking & faculty fees$723,09580%
- Travel & lodging$85,2079%
- Food & beverage$38,7944%
- Education$1150%
- Entertainment$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$331,164
- INTELLIS ADAPTIVESTIM$246,923
- SYNCHROMED$137,997
- INTELLIS$44,788
- VANTA ADAPTIVESTIM$25,821
- RESTORE$8,508
- mild Device Kit$8,248
- Prometra II$7,228
- Proclaim Family of SCS IPGs$6,364
- PRIALT$5,951
- MYSTIM$3,960
- OSTEOCOOL RF ABLATION$3,520
- LIORESAL$2,992
- RESTORESENSORSURESCAN$2,718
- KYPHON EXPRESS II KYPHOPAK TRAY$2,663
- VISUALASE$2,500
- OSTEOCOOL RF ABLATION SYSTEM$2,000
- Inflate FX$1,760
- KYPHON Balloon Kyphoplasty$1,650
- Seglentis$1,275
How this compares
$904,610 in reported general payments places this provider in the 95th percentile of 891 anesthesiology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 122 | $87,314 |
| Xtampza ErOxycodone Myristate | 90 | $61,260 |
| RelistorMethylnaltrexone Bromide | 22 | $60,996 |
| Nucynta ErTapentadol Hcl | 40 | $41,335 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,633 | $38,188 |
| Buprenorphine | 176 | $32,235 |
| MovantikNaloxegol Oxalate | 68 | $32,120 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,295 | $31,877 |
| OxycontinOxycodone Hcl | 48 | $29,333 |
| Diflorasone Diacetate | 36 | $26,167 |
| Gabapentin ErGabapentin | 16 | $13,897 |
| Fentanyl | 135 | $10,960 |
| Pregabalin | 400 | $7,978 |
| HorizantGabapentin Enacarbil | 12 | $7,486 |
| Morphine Sulfate ErMorphine Sulfate | 320 | $7,436 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta Er | $861 | $189,909252 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $1,672 | $60,99622 claims |
| Redhill Biopharma Inc.Movantik | $150 | $32,12068 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $115 | $7,48612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 891 anesthesiology providers in Missouri.
Other anesthesiology in Saint Louis
- Mitchell FingermanSaint Louis$229K
- Evan KharaschSaint Louis$57K
- Terri MonkSaint Louis$42K
- Quoc DangSaint Louis$29K
- Peter NageleSaint Louis$25K
- Gary HaynesSaint Louis$13K
- Helga KomenSaint Louis$10K
- Ilesha ShahSaint Louis$10K
- Abigail YorkSaint Louis$9K
- Rida ChaudhrySaint Louis$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.